Last reviewed · How we verify
Crinone vaginal progesterone gel
At a glance
| Generic name | Crinone vaginal progesterone gel |
|---|---|
| Sponsor | Wake Forest University Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy (NA)
- Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. (PHASE3)
- Randomized Trial of Maternal Progesterone Therapy (PHASE2)
- Uterine Electrical Activity Before and After Progesterone Treatment for Preterm Labor (NA)
- The Effect of Luteal Blood Progesterone Levels on Ongoing Pregnancy Rates (NA)
- Sexual Absorption of Vaginal Progesterone (PHASE4)
- An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) (PHASE3)
- Luteal Support in Frozen-Thawed Embryo Transfer Cycles (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: